Drug Shortage Report for SANDOZ MONTELUKAST
Report ID | 168455 |
Drug Identification Number | 02358611 |
Brand name | SANDOZ MONTELUKAST |
Common or Proper name | MONTELUKAST |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 4MG |
Dosage form(s) | GRANULES |
Route of administration | ORAL ORAL |
Packaging size | 30OGR |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2022-09-01 |
Estimated end date | 2022-11-04 |
Actual end date | 2022-11-09 |
Shortage status | Resolved |
Updated date | 2022-11-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-11-16 | French | Compare |
v4 | 2022-11-16 | English | Compare |
v3 | 2022-09-02 | English | Compare |
v2 | 2022-09-01 | French | Compare |
v1 | 2022-09-01 | English | Compare |
Showing 1 to 5 of 5